Acadia Healthcare Company (ACHC) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Acadia Healthcare Company

NasdaqGS•Healthcare•Medical Care Facilities

$28.77+0.61(0.02%)Market open

Market Cap

$2.57B

P/S

0.8x

P/B

1.3x

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

How this company scores

WeakMetricSide Score: 32/100

Strongest: Growth (11/25); weakest: Cash & Earnings Quality (3/25).

Profitability9/25

Growth11/25

Balance Sheet & Red Flags9/25

Cash & Earnings Quality3/25

Strengths

Consistent growthImproving marginsNo share dilution

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 20.7x5y range 13.9x – 28.1x

Currently near its 12-quarter median.

P/S · 0.8x5y range 0.4x – 4.0x

Currently below its 20-quarter median.

P/B · 1.3x5y range 0.7x – 2.6x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

Operating margins dropped 646.2% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.

Earnings Quality

Red Flag

Free cash flow has been negative in 7 of the last 8 quarters — earnings are not translating to cash.

Price & Volume

Market Cap $2.57B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $3.37B
Q. Revenue: $865.84M
TTM EBITDA: $-900.37M
TTM Op. Income: $-1.10B
Q. Op. Income: $22.01M
TTM Net Income: $-1.13B
Q. Net Income: $10.93M
EPS: $0.12
Shares Out.: $90.82M

$3.37B in TTM revenue grew 4.3% YoY, reaching $865.84M last quarter. TTM EBITDA of $-900.37M and TTM operating income of $-1.10B show growth is flowing through to the bottom line. However, net income is negative at $1.13B — growth is not yet reaching the bottom line. Over the past year, TTM revenue is up 4% — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: 8.4%
Op. Margin: 2.5%
Net Margin: 1.3%

Op. margin of 2.5% is down 3.2% YoY — costs are rising relative to revenue. Net margin at 1.3% Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 0.8x
P/B Ratio: 1.3x

P/S of 0.8x and P/B of 1.3x. P/S is low relative to typical market levels. Over the past year, P/E is down 0% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $5.55B
Cash: $171.29M
Long-Term Debt: $2.38B
Book Value: $1.98B
D/E Ratio: 1.2
Debt/EBITDA: 32.9

With $5.55B in assets and $2.38B in long-term debt, D/E is 1.2and book value is $1.98B — moderate leverage. Over the past year, debt/equity is up 65% — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $162.07M
TTM Free Cash Flow: $-134.03M
FCF Margin: -4.0%
FCF / Net Income: 0.1

TTM FCF of $-134.03M on $162.07M in operating cash flow. The FCF / Net Income ratio of 0.1x means cash covers only part of net income — earnings quality needs attention. Across the last 8 quarters, free cash flow has risen for 2 consecutive quarters — an improving trend.